Clinical Trials
9
Active:0
Completed:5
Trial Phases
1 Phases
Not Applicable:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (100.0%)Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract Infections
Not Applicable
Completed
- Conditions
- Upper Respiratory Tract Infection Bacterial
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- AronPharma Sp. z o. o.
- Target Recruit Count
- 60
- Registration Number
- NCT06020001
- Locations
- 🇵🇱
Pomorskie Centrum Reumatologiczne im. dr Jadwigi Titz-Kosko, Sopot, Poland
Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resection
Not Applicable
Recruiting
- Conditions
- Immunomodulation
- First Posted Date
- 2023-08-30
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- AronPharma Sp. z o. o.
- Target Recruit Count
- 30
- Registration Number
- NCT06017661
- Locations
- 🇵🇱
Uniwersyteckie Centrum Kliniczne, Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólne, Gdańsk, Poland
Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3
Not Applicable
Completed
- Conditions
- Bioavailability of Vitamin D
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- AronPharma Sp. z o. o.
- Target Recruit Count
- 27
- Registration Number
- NCT06010121
- Locations
- 🇵🇱
Gdański Uniwersytet Medyczny, Gdańsk, Poland
Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Prevention of Ocular Diseases
Not Applicable
Completed
- Conditions
- Eye Abnormalities
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- AronPharma Sp. z o. o.
- Target Recruit Count
- 22
- Registration Number
- NCT06004570
- Locations
- 🇵🇱
Centrum Zdrowia Eter-Med sp. z o.o., Gdańsk, Poland
The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism
Not Applicable
Recruiting
- Conditions
- PreDiabetesDiabetes in Adolescence
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- AronPharma Sp. z o. o.
- Target Recruit Count
- 30
- Registration Number
- NCT05994586
- Locations
- 🇵🇱
Pomorskie Centrum Reumatologiczne im. dr Jadwigi Titz-Kosko, Sopot, Poland
- Prev
- 1
- 2
- Next
News
No news found